Related Concept Videos
01:23Antidepressant Drugs: MAOIs and Other Agents
Atypical antidepressants, including bupropion (Wellbutrin), mirtazapine (Remeron), nefazodone (Serzone), trazodone (Desyrel), and vilazodone (Viibryd), offer unique mechanisms of action. Bupropion weakly inhibits dopamine and norepinephrine reuptake, aiding depression treatment and smoking cessation, with a low risk of sexual dysfunction. Mirtazapine enhances serotonin and norepinephrine neurotransmission, leading to sedation, increased appetite, and weight gain. As a result, it helps treat...
01:26Modeling in Therapy
Modeling, a key technique in therapy, uses observational learning to help clients acquire and practice new skills by watching therapists demonstrate desired behaviors. This approach, rooted in Albert Bandura's concept of vicarious learning, plays a significant role in therapeutic interventions for various psychological conditions, including social anxiety, ADHD, and depression.
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
Participant Modeling
Participant modeling involves therapists demonstrating calm and effective behaviors in situations...
01:25Antidepressant Drugs: Overview
Antidepressant drugs are a class of medications primarily used for treating various mood disorders, including major depression, anxiety disorders, and other related conditions. These medicines work by modulating the neurotransmitter balance within the brain, alleviating depressive symptoms. Antidepressants can be broadly categorized into several groups according to their mechanism of action and chemical structure: Selective Serotonin Reuptake Inhibitors (SSRIs), Serotonin-Norepinephrine...
01:28Antidepressant Drugs: Tricyclics, SSRIs, and SNRIs
Tricyclic Antidepressants (TCAs), including Desipramine (Norpramin), Imipramine (Tofranil), Clomipramine (Anafranil), and Amitriptyline (Elavil), inhibit serotonin and norepinephrine reuptake and also block other receptors. They are used for depression, pain conditions, and insomnia. Common adverse effects include anticholinergic effects, sedation, orthostatic hypotension, and weight gain. They have a narrow therapeutic window and so require plasma-level monitoring. Abrupt discontinuation can...
01:28Drug Therapy
The advent of drug therapy has profoundly shaped modern mental health care, providing targeted treatments for a range of psychological disorders. Psychotherapeutic drugs, classified into antianxiety, antidepressant, and antipsychotic medications, address symptoms across anxiety disorders, mood disorders, and schizophrenia. While these medications have transformed patient outcomes, they require careful management due to their potential side effects and limitations.
Antianxiety Medications
Antianxiety Medications
01:21G-protein Coupled Receptors
G-protein coupled receptors are ligand binding receptors that indirectly affect changes in the cell. The actual receptor is a single polypeptide that transverses the cell membrane seven times creating intracellular and extracellular loops. The extracellular loops create a ligand specific pocket which binds to neurotransmitters or hormones. The intracellular loops holds onto the G-protein.
You might also read
Related Articles
Articles linked to this work by shared authors, journal, and citation graph.
Sort by
Same author
Advanced Methods for Dose and Regimen Finding During Drug Development: Summary of the EMA/EFPIA Workshop on Dose Finding (London 4-5 December 2014).
CPT: pharmacometrics & systems pharmacology·2017
Same author
Model Evaluation of Continuous Data Pharmacometric Models: Metrics and Graphics.
CPT: pharmacometrics & systems pharmacology·2016
Same author
The use of model-based tumor-size metrics to predict survival.
Clinical pharmacology and therapeutics·2014
Related Experiment Video
Updated: May 20, 2026
05:42
The Forced Swim Test as a Model of Depressive-like Behavior
Published on: March 2, 2015
Modeling helps in understanding antidepressants.
1Department of Pharmacology and Clinical Pharmacology, University of Auckland, Auckland, New Zealand. n.holford@auckland.ac.nz
Clinical Pharmacology and Therapeutics
|July 21, 2012
Summary
Understanding antidepressant drug pharmacology is complex due to challenges in defining depression, treatment response timelines, and patient withdrawal from studies. A recent article by Russu et al. tackled these issues.
Area of Science:
- Pharmacology
- Psychiatry
- Clinical Trials
Background:
- Clinical pharmacology of antidepressant drugs presents significant challenges.
- Difficulties include defining the depressed state and the time course of treatment response.
- Frequent patient withdrawal from clinical trials further complicates research.
Purpose of the Study:
- To address the challenges in describing the clinical pharmacology of antidepressant drugs.
- To build upon the findings presented in the recent article by Russu et al.
Main Methods:
- Review of existing literature on antidepressant clinical pharmacology.
- Analysis of methodologies used to overcome challenges in describing treatment response and patient withdrawal.
- Synthesis of information from the Russu et al. publication.
Main Results:
- The article by Russu et al. successfully addressed key challenges in antidepressant drug pharmacology.
- Specific strategies for defining the depressed state and response timelines were highlighted.
- Methods for managing and analyzing patient withdrawal data were discussed.
Conclusions:
- Overcoming challenges in clinical trial design and patient reporting is crucial for advancing antidepressant pharmacology.
- Further research can build upon the methodologies presented to improve our understanding of these drugs.
- Accurate description of antidepressant drug effects requires careful consideration of patient state and trial conduct.